HOPE for Human Extended Criteria and Donation After Brain Death Donor (ECD-DBD) Liver Allografts (HOPE-ECD-DBD)
Hypothermic Oxygenated Machine Perfusion (HOPE) for Liver Transplantation of Human Liver Allografts From Extended Criteria Donors (ECD) in Donation After Brain Death (DBD); a Multicenter Randomized Controlled Trial (HOPE ECD-DBD)
Sponsor: University Hospital, Aachen
This NA trial investigates Hepatocellular Injury and Liver Transplant and is currently completed. University Hospital, Aachen leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2021 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
▶ Show 6 earlier versions
-
Nov 2019 — Nov 2020 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Nov 2019 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
-
Sep 2017 — Oct 2017 [monthly]
Recruiting NA
-
Aug 2017 — Sep 2017 [monthly]
Recruiting NA
-
May 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Aachen
For direct contact, visit the study record on ClinicalTrials.gov .